Food Safety Incidents

Failure to prepare a written master manufacturing record has been detected in Nutritional Supplements.

Written by SGS Digicomply Editorial Team | Sep 29, 2025 10:00:00 PM

Incident Report: Nutritional Supplements Manufacturing Compliance Issue

On September 30, 2025, a significant compliance issue was identified concerning the manufacturing of nutritional supplements in the United States. The incident pertains to the failure to prepare a written master manufacturing record, which is a critical component in ensuring the safety and quality of dietary products.

The master manufacturing record serves as a comprehensive guide for the production process, detailing the specific ingredients, equipment, and procedures required to manufacture a product consistently and safely. The absence of such documentation can lead to inconsistencies in product formulation, potential contamination, and deviations from established safety standards.

Compliance with manufacturing regulations is essential for maintaining consumer safety and trust in nutritional supplements. The U.S. Food and Drug Administration emphasizes the importance of proper documentation and adherence to Good Manufacturing Practices (GMP) to mitigate risks associated with dietary products.

In light of this incident, it is crucial for manufacturers to review their production protocols and ensure that all necessary records are accurately maintained. This will not only help in complying with regulatory requirements but also in safeguarding public health by ensuring that all nutritional supplements are produced under stringent safety standards.

Continued vigilance and adherence to manufacturing guidelines are vital in the dietary supplement industry to prevent future incidents and protect consumers.

  • Incident: Failure to prepare a written master manufacturing record has been detected in Nutritional Supplements.
  • Date: 2025-09-30
  • Product: Nutritional Supplements
  • Market: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Origin of issue: United States of America
  • Hazard: Available to SGS Digicomply users only. Explore the platform (for enterprises, no individual plans)
  • Incident Category: Other incident
  • Source: U.S. Food and Drug Administration